Nightmare Bacteria Infection Rates Spike Nearly 70% Since 2019, CDC Says
A disturbing trend has emerged in the United States: infection rates from "nightmare bacteria" have skyrocketed nearly 70% since 2019, according to a new report from the Centers for Disease Control and Prevention (CDC). The alarming increase is attributed primarily to bacteria carrying the NDM gene, which makes them resistant to multiple antibiotics.
The CDC researchers published their findings in the Annals of Internal Medicine on Monday, highlighting the growing concern over the rise of these superbugs. "The rate of U.S. cases jumped more than fivefold in recent years," said David Weiss, an Emory University infectious diseases researcher. "This is a grave danger and very worrisome."
The NDM gene, short for New Delhi metallo-beta-lactamase, was once considered exotic, linked to a small number of patients who received medical care overseas. However, the numbers are no longer small, and the CDC warns that this trend poses significant public health risks.
Only two antibiotics, tigecycline and colistin, work against infections caused by NDM-carrying bacteria. These medications are expensive and must be administered intravenously, making them inaccessible to many patients. "This is a ticking time bomb," said Dr. Weiss. "We need to take action now to prevent the spread of these superbugs."
The CDC report emphasizes that the rise of NDMs in the U.S. is largely driven by international travel and healthcare-associated infections. As more people travel abroad, they may be exposed to these resistant bacteria, which can then be brought back into the country.
To combat this growing threat, the CDC recommends that healthcare professionals take a proactive approach to infection control. This includes implementing strict hygiene practices, using personal protective equipment (PPE), and ensuring proper antibiotic use.
Background Context
The emergence of NDM-carrying bacteria has been a concern for years, particularly in countries with limited access to antibiotics. However, the recent spike in U.S. cases highlights the need for increased vigilance and cooperation among healthcare providers, public health officials, and patients themselves.
Additional Perspectives
Dr. Weiss emphasized that prevention is key: "We can't just rely on antibiotics; we need to take a holistic approach to infection control." He recommends that individuals practice good hygiene, such as washing their hands frequently and thoroughly, especially after using the bathroom or before eating.
The CDC also stresses the importance of consulting healthcare professionals when experiencing symptoms. Early detection and treatment can significantly improve outcomes for patients with NDM infections.
Current Status and Next Developments
As the situation continues to unfold, the CDC will work closely with state health departments and other partners to monitor the spread of these superbugs. The agency will also provide guidance on infection control measures and antibiotic stewardship strategies.
In the meantime, individuals can take steps to protect themselves by practicing good hygiene, staying informed about local outbreaks, and seeking medical attention promptly if they experience symptoms.
The fight against "nightmare bacteria" requires a collective effort from healthcare professionals, public health officials, and patients. By working together, we can mitigate this growing threat and ensure that these superbugs do not become the norm in the United States.
*Reporting by Fortune.*